WANG, JIAN MIN
 Distribuzione geografica
Continente #
AS - Asia 86
NA - Nord America 39
EU - Europa 30
SA - Sud America 6
AF - Africa 3
OC - Oceania 1
Totale 165
Nazione #
US - Stati Uniti d'America 38
CN - Cina 36
SG - Singapore 20
RU - Federazione Russa 12
HK - Hong Kong 10
KR - Corea 9
BR - Brasile 4
VN - Vietnam 4
FI - Finlandia 3
NL - Olanda 3
PL - Polonia 3
DE - Germania 2
FR - Francia 2
GB - Regno Unito 2
ID - Indonesia 2
IN - India 2
IT - Italia 2
JP - Giappone 2
NG - Nigeria 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
EC - Ecuador 1
KE - Kenya 1
MX - Messico 1
UA - Ucraina 1
Totale 165
Città #
Singapore 11
Hong Kong 9
Seoul 9
Hefei 8
San Jose 8
Council Bluffs 6
Shenzhen 5
Ashburn 4
Beijing 4
Los Angeles 3
Warsaw 3
Abuja 2
Brooklyn 2
Frankfurt am Main 2
Haiphong 2
Helsinki 2
Lauterbourg 2
London 2
New York 2
Shanghai 2
Tokyo 2
Agudo 1
Akron 1
Anápolis 1
Bhubaneswar 1
Buffalo 1
Changsha 1
Chennai 1
Contagem 1
Da Nang 1
Elk Grove Village 1
Ho Chi Minh City 1
Honolulu 1
Jakarta 1
Jersey City 1
Kent 1
Kyiv 1
Lappeenranta 1
Melbourne 1
Milan 1
Monterrey 1
Nairobi 1
Orem 1
Pasadena 1
Rio das Ostras 1
Riobamba 1
Rome 1
Rotterdam 1
San Antonio 1
San Francisco 1
San Miguel de Tucumán 1
Santa Clara 1
Snellville 1
Tianjin 1
Totale 123
Nome #
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial 94
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial 73
Totale 167
Categoria #
all - tutte 470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202535 0 0 0 0 0 8 11 2 1 2 7 4
2025/2026132 15 23 18 10 15 4 15 2 10 12 8 0
Totale 167